Expert Comment – Mixed effectiveness of chatbots in increasing COVID-19 vaccine confidence in AsiaThursday 8 June 2023
Low traffic neighbourhoods in London borough cut daily driving among residents by 1.3kmWednesday 7 June 2023
Novel mHealth Interventions for Priority Populations Among People with HIV in Africa
LSHTM, Keppel Street, London, United Kingdom
Working in A&E and studying Public Health at the same time - Candy's part-time experienceTuesday 23 May 2023
GlaxoSmithKline welcomes LSHTM scholarship recipients to their Head OfficeFriday 5 May 2023
As clinical researchers, we are motivated by knowing that the type of work and research we do can ultimately make a positive impact on our global health. We hope to contribute to scientific knowledge that will inform policy decisions on the introduction and use of vaccines. We also hope to improve their accessibility and affordability. This is crucial for reducing the burden of vaccine-preventable diseases like pneumonia in low- and middle-income countries, and ensuring that vulnerable populations are not left behind.
Meat and dairy-reduction policies would help meet net zero targets and improve population health in the UK
To meet the UK’s greenhouse gas (GHG) emissions targets, the Climate Change Committee (CCC) recommended to reduce current meat and dairy intake by 20% by 2030. Compared to plant-based, animal products have significant higher carbon emissions and land and water footprints. A shift towards plant-based diets, rich in fruit and vegetables, nuts and wholegrains would also reduce the risk of mortality and chronic disease morbidity, including cardiovascular disease, cancer and type 2 diabetes.
Today, World Environment Day 2023 is all about tackling plastic pollution. This is timely not least as countries around the world emerge from a week of international negotiations as part of the development of a global, legally binding, treaty to end plastic pollution. Plastic is now so pervasive in our environment as to constitute a new era: the Plasticene.
The management of the cancer backlog following the COVID-19 pandemic is one of the UK’s major political and clinical issues. Figures for September 2022 show for example that only 61.7% of patients are receiving treatment within 62 days of a referral, compared to 82.3% in the period between April 2017 and March 2018. Short-term public health solutions are urgently required to address current delays in treatment.